O
Olarn Roengvoraphoj
Researcher at Ludwig Maximilian University of Munich
Publications - 43
Citations - 453
Olarn Roengvoraphoj is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Chemoradiotherapy & Lung cancer. The author has an hindex of 11, co-authored 43 publications receiving 270 citations.
Papers
More filters
Journal ArticleDOI
Recent advances of PET imaging in clinical radiation oncology
Marcus Unterrainer,Marcus Unterrainer,Chukwuka Eze,Harun Ilhan,Sebastian Marschner,Olarn Roengvoraphoj,Nina-Sophie Schmidt-Hegemann,Franziska Walter,Wolfgang G. Kunz,P. Munck af Rosenschöld,Robert Jeraj,Nathalie L. Albert,Nathalie L. Albert,Anca-Ligia Grosu,Maximilian Niyazi,Maximilian Niyazi,Peter Bartenstein,Peter Bartenstein,Claus Belka,Claus Belka +19 more
TL;DR: Recent and current advances of PET imaging within the field of clinical radiotherapy / radiation oncology in several oncological entities are focused on with particular emphasis on radiotherapy planning, response assessment after radiotherapy and prognostication.
Journal ArticleDOI
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
Lukas Käsmann,Chukwuka Eze,Julian Taugner,Olarn Roengvoraphoj,Maurice Dantes,Nina-Sophie Schmidt-Hegemann,Sanziana Schiopu,Claus Belka,Farkhad Manapov +8 more
TL;DR: The immunological rationale and current trials investigating chemoradioimmunotherapy for inoperable stage III NSCLC are discussed and predictive biomarkers and improvement of patient selection and monitoring are discussed.
Journal ArticleDOI
Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging
Chukwuka Eze,Olarn Roengvoraphoj,Maximilian Niyazi,Guido Hildebrandt,Rainer Fietkau,Claus Belka,Farkhad Manapov +6 more
TL;DR: In real‐life patients comprehensively staged with cranial magnetic resonance imaging, treatment response and PCI strongly correlated with prolonged overall survival, time to progression, and brain metastasis–free survival.
Journal ArticleDOI
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes.
Farkhad Manapov,Lukas Käsmann,Olarn Roengvoraphoj,Maurice Dantes,Nina-Sophie Schmidt-Hegemann,Claus Belka,Chukwuka Eze +6 more
TL;DR: The aim of this review is to present a summary and update of the latest evidence for patient selection, efficacy and outcome of prophylactic cranial irradiation.
Journal ArticleDOI
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
K. Gennen,Lukas Käsmann,Julian Taugner,Chukwuka Eze,Monika Karin,Olarn Roengvoraphoj,Jens Neumann,Amanda Tufman,M. Orth,Simone Reu,Claus Belka,Farkhad Manapov +11 more
TL;DR: Assessment of PD-L1 expression on tumor cells in combination with CD8+ TIL density can be a predictive biomarker in patients with inoperable LA-NSCLC treated with concurrent CRT and Evaluation of Tumor Immunity in the MicroEnvironment appears to be an independent prognostic factor for local control, PFS and OS.